McKesson Acquires Controlling Interest in PRISM Vision Holdings
April 8, 2025
McKesson Corporation completed the acquisition of an approximate 80% controlling interest in PRISM Vision Holdings, LLC for about $850 million. PRISM physicians will retain an approximate 20% interest, and PRISM Vision will be consolidated within McKesson’s U.S. Pharmaceutical segment.
- Buyers
- McKesson Corporation
- Targets
- PRISM Vision Holdings, LLC
- Sellers
- Quad-C Management, Inc.
- Industry
- Healthcare Services
- Location
- Virginia, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
World Insurance Associates Acquires Prism (PRISM Insurance Group)
July 1, 2023
Insurance
World Insurance Associates LLC acquired the business of Prism (PRISM Insurance Group) of Cedarhurst, New York effective July 1, 2023; terms were not disclosed. Prism, founded in the mid-1990s, specializes in insurance brokerage and risk management for the healthcare industry—particularly workers' compensation and professional liability—and will join World’s national insurance brokerage platform to expand its healthcare-focused capabilities and service footprint.
-
Vistra to Acquire Minority Equity Interests in Vistra Vision LLC
September 18, 2024
Energy
Vistra executed definitive agreements to acquire the remaining 15% equity interests in Vistra Vision LLC from minority affiliates of Nuveen Asset Management and Avenue Capital Management. The deal is expected to close on December 31, 2024, with a net present value purchase price of $3.085 billion (paid in installments over two years, subject to dividend-based adjustment).
-
McKesson Signs Agreement to Acquire Rx Savings Solutions
September 19, 2022
Healthcare Services
McKesson Corporation has signed a definitive agreement to acquire Rx Savings Solutions (RxSS), a prescription price transparency and benefit insight company focused on affordability and medication adherence for health plans and large self-funded employers. The transaction is valued up to $875 million ($600 million upfront plus up to $275 million contingent on RxSS performance through calendar year 2025) and is expected to close in the second half of fiscal 2023, subject to customary regulatory approvals. Following closing, RxSS will become part of McKesson’s Prescription Technology Solutions business.
-
Charme Capital Partners Acquires Prism Healthcare
March 1, 2022
Medical Devices
Charme Capital Partners’ Charme IV fund has acquired Prism Healthcare, a UK-based manufacturer and provider of specialist patient handling and care equipment. Limerston Capital will remain invested alongside the management team; Charme’s investment will support Prism’s organic growth, international expansion and continued buy-and-build strategy.
-
Hyperion Materials & Technologies Acquires Prism Technologies, Inc.
April 29, 2024
Manufacturing
Hyperion Materials & Technologies announced an agreement to acquire Prism Technologies, Inc., an Elizabeth, Pennsylvania-based manufacturer of compaction tooling, specialty components and wear parts. Prism will be integrated into Hyperion’s Precision Solutions business unit to add compaction tooling capabilities and capacity; the transaction is expected to close subject to customary conditions.
-
Avista Capital Partners and VHC Investco Acquire Vision Healthcare NV
June 1, 2020
Consumer Products
Avista Capital Partners, together with VHC Investco and company management, acquired Belgium-based Vision Healthcare NV in a transaction valuing the company at €305 million (approximately $336 million). Avista and VHC Investco/management will each hold a 50% ownership interest; the partnership will support Vision's omni-channel, direct-to-consumer growth and geographic expansion across Europe and beyond.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.